case presentation - cleveland clinic 3...case, cont’d recurrent morning swelling, pain, and...
TRANSCRIPT
New Adult Clinical
Autoinflammatory Disease Case
Qingping Yao, MD, PhD
Senior Staff
Department of Rheumatic and Immunologic Diseases
Cleveland Clinic
Cleveland, OH
Case presentation
A 45-year old white F
Recurrent erythematous rash 1 yr
Rash lasted 3 to 7 days and disappeared for 1 to 2 days
Photo: erythematous plaques and patches
Case, cont’d
Recurrent morning swelling, pain, and weakness in
the hands and feet, rarely forearms and knees
Recurrent blurred vision
3 to 7 days/episode. Severe abdominal pain lasting
about 2 hours AM
She denied fevers.
Case, cont’d
ROS: wt loss, night sweats, and dry mouth, IBS type.
FH: negative
Born in Wales and married with healthy 2 children.
PE: skin changes, otherwise negative
Labs
CBC, CMP, UA all wnl
ESR, serology, CK and aldolase wnl
EGD and Colonoscopy negative
Ophthal exam: normal
Lip minor salivary gland bx: negative
DDX
FMF
TRAPS
Blau’s syndrome
NAID
Genetic testing
NOD2 gene mutation: heterogygous
IVS8+158, R702W
TNFRSF1A for TRAPS: negative
NOD2-associated autoinflammatory
disease (NAID)
Newly reported disease
White adult onset mostly
Phenotype:
-Periodic fever, dermatitis and polyarthritis
-Features: Spongiotic dermatitis and pedal swelling
Genotype: NOD2 variants: IVS8+158, R702W and R703C
Characteristics of Cumulative Clinical and
Laboratory Manifestations of NAID Patients
Positive NOD2
Variable patients (n=22)
Gender (Female/Male) 13/9
Mean age at diagnosis (range, years) 40.1 (17-72)
Mean disease duration (range, years) 4.7 (1-13)
Ethnicity (White) 22/22 (100%)
Familial 3/22 (13.6%)
Weight loss 13/22 (59.1%)
Fever 13/22 (59.1%)
Skin disease 19/22 (86.4%)
Arthritis/arthralgia 20/22 (90.9%)
Gastrointestinal 13/22 (59.1%)
Serositis/chest pain 5/22 (22.7%)
Sicca-like 9/22 (40.9%)
Pulmonary 3/22 (13.6%)
Uveitis 0/22 (0%)
Raised ESR/CRP 9/20 (45.0%)
ESR, erytherocyte sendimentation rate; CRP, C-reactive protein
Pathogenesis of NAID
Interaction: gene mutations+environment (GI
stress, trauma)
Cytokines: Th1/Th2 might not play a role. IL-
17 and some type of T cells may contribute
Under investigation
Therapy and Prognosis for NAID
Depends on signs and symptoms
Topical steroids
Small dose of prednisone
Sulfasalazine
Biologics
Patients appear to run benign and intermittent course; some have nearly persistent polyarthritis, fatigue, rash, and fever
References Yao Q, et al. A new category of autoinflammatory disease associated with NOD2
gene mutations. Arthritis Res Ther. 2011;13(5):R148. doi: 10.1186/ar3462. Epub
2011 Sep 14.
Yao Q, et al. Dermatitis as a characteristic phenotype of a new autoinflammatory
disease associated with NOD2 mutations. J Am Acad Dermatol. 2013
Apr;68(4):624-31. doi: 10.1016/j.jaad.2012.09.025. Epub 2012 Oct 24.
Yao Q, et al. Granulomatous pneumonitis associated with adult-onset Blau-like
syndrome. Am J Respir Crit Care Med. 2012 Sep 1;186(5):465-6.
Yao Q. Nucleotide-binding oligomerization domain containing 2: Structure,
function, and diseases. Semin Arthritis Rheum. 2013 Jan 24. pii: S0049-
0172(12)00287-9. doi: 10.1016/j.semarthrit.2012.12.005. [Epub ahead of print]
Yao Q, et al. Distal lower extremity swelling as a prominent phenotype of NOD2-
associated autoinflammatory disease. Rheumatol (Oxford), 2013 Apr 12. [Epub
ahead of print]